Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1) - a randomized, placebo-controlled phase IIa dose escalation trial targeting disease tolerance to infection
Sebastian Weis, Luís Ferreira Moita, Daniel Thomas‐Rueddel, Peter Schlattmann et autres